Dr. Markham is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
705 Riley Hospital Dr
# RI1134
Indianapolis, IN 46202Phone+1 317-944-8906Fax+1 317-944-9330
Education & Training
- Cincinnati Children's Hospital Medical CenterFellowship, Pediatric Cardiology, 2001 - 2004
- University of Arkansas for Medical Sciences (UAMS) College of MedicineResidency, Internal Medicine/Pediatrics, 1996 - 2000
- East Tennessee State University James H. Quillen College of MedicineClass of 1996
Clinical Trials
- Eisenmenger Quality Enhancement Research Initiative Start of enrollment: 2012 Jul 01
- Adult Congenital Heart Disease Registry (QuERI) Start of enrollment: 2011 Dec 01
- Valsartan for Attenuating Disease Evolution In Early Sarcomeric HCM Start of enrollment: 2014 Mar 01
- Join now to see all
Publications & Presentations
PubMed
- Family functioning and health-related quality of life in children and young adults with Marfan syndrome.Lauren S Crafts, Lynn A Sleeper, Karen Uzark, Andrew M Atz, Timothy J Bradley
Quality of Life Research. 2025-03-18 - Physical Activity Correlates With Skeletal Muscle MRI Findings in Individuals With Duchenne Muscular Dystrophy.Jaclyn Tamaroff, Nicholas Joy, Bruce Damon, Larry W Markham, Thomas Donnelly
Muscle & Nerve. 2025-03-01 - Physical activity and cardiac function in patients with Duchenne muscular dystrophy.Mary Killian, Jaclyn Tamaroff, Karry Su, Kimberly Crum, Kristen George-Durrett
Cardiology in the Young. 2025-02-27
Journal Articles
- 2017 Riley Heart Center Symposium on Cardiac Development: Development and Repair of the Ventricular WallLarry Markham, MD, Pediatric Cardiology
Press Mentions
- Riley Nurse Using Her Journey with Congenital Heart Defects to Relate to FamiliesFebruary 19th, 2021
- FDA Awards $1M to Phase 2 Study of Ifetroban in Treating Heart Disease Linked to Duchenne MDOctober 2nd, 2019
- A Protein Could Be Key to Preserving Heart Function in DMD in ChildrenAugust 1st, 2018
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: